The Egyptian Journal of Radiology and Nuclear Medicine (Dec 2019)

T2* dynamic contrast enhanced MR perfusion for cervical cord lesions; does it work?

  • Mohamed Saied Abdelgawad,
  • Mohamed Ihab Samy Reda,
  • Nermeen Abd El-Monsef Abd El-Maaboud

DOI
https://doi.org/10.1186/s43055-019-0091-y
Journal volume & issue
Vol. 50, no. 1
pp. 1 – 10

Abstract

Read online

Abstract Background The goal of this work was to assess the value of magnetic resonance (MR) perfusion in narrowing the differential diagnosis of cord lesions. Thirty eight patients with different cervical cord lesions were involved in this study. This includes 20 males and 18 females, ranging between 13 and 60 years old. Conventional MR with T2W (axial and sagittal) and pre and post contrast T1W (axial and sagittal) in addition to the T2* MR perfusion sequence were done. The final diagnosis of cervical cord tumors was achieved by biopsy and histopathological diagnosis, while inflammatory lesions were proved by clinical, laboratory data and follow-up for six months. Results Neoplastic lesions were found in 13 patients, while 25 patients had inflammatory lesions. Relative cord/cerebral blood volume (rCBV) was significantly higher in neoplastic lesions when compared to non-neoplastic ones (2 ± 1.13 vs 1.01 ± 0.62), respectively. A cutoff value of 1.38 or higher has high sensitivity of 78% and specificity of 83% in differentiating between these lesions. Conclusion T2* is a valuable technique in differentiating neoplastic from non-neoplastic cervical cord lesions.

Keywords